key: cord-0042421-0iwm3raw authors: Jackson, Ronald S. title: Wine and Health date: 2008-12-19 journal: Wine Science DOI: 10.1016/b978-012373646-8.50015-9 sha: f0be7966ee571872babc08002ed7253196d4137b doc_id: 42421 cord_uid: 0iwm3raw nan The contrasting social and antisocial effects of alcohol consumption must have become evident shortly after the discovery of winemaking. Time has only augmented our understanding of the multifaceted nature of this Dr Jekyll-Mr Hyde phenomenon. It is clear that excessive alcohol consumption, both acute and chronic, can have devastating effects on physical and mental wellbeing. Excessive ethanol consumption can cause cirrhosis of the liver, increase the likelihood of hypertension and stroke, favor the development of breast and digestive tract cancers, and induce fetal alcohol syndrome. Many of these effects may stem from the activation of free-radical damage induced by high alcohol intake (Meagher et al., 1999) . Because the problems associated with alcoholism (Abrams et al., 1987; Schmitz and Gray, 1998) , and the cerebral chemical changes associated with addiction (Nestler and Malenka, 2004; Heinz, 2006) have been well documented, they will not 12 Wine and Health be discussed here. On the other hand, it is becoming equally clear that moderate wine consumption (250-300 ml/day -about one-third of a 750-ml bottle) has distinct health benefi ts. Multiple epidemiological studies suggest that daily, moderate, alcohol consumption (Thun et al., 1997; Doll et al., 2005) , and especially wine (Grønbaek et al., 2000; Renaud et al., 2004) is associated with a reduction in all-cause mortality. This is expressed in a U-shaped curve, with increased mortality being associated with both excess alcohol intake and abstinence. This is particularly evident in the reduced incidence of cardiovascular disease in moderate alcohol consumers. In addition, it reduces the likelihood of type 2 diabetes, combats hypertension, and reduces the frequency of certain cancers and several other diseases. These epidemiological correlations are being supported by in vivo studies that provide molecular explanations for these associations. The principal element missing in confi rming a causal relationship involves detailed information on the dynamics of absorption, metabolism, and elimination of the proposed active ingredients. Faced with a chemical and beverage that can be not only salubrious but also addictive, the fl uctuations in society's attitude toward alcohol are not surprising (Musto, 1996; Pittman, 1996; Vallee, 1998) . Thankfully for those in the wine industry, wine drinkers are less likely to show those alcohol-related problems that have given alcohol a bad reputation (Smart and Walsh, 1999) . In addition, wine has a higher social image than other alcoholic beverages (Klein and Pittman, 1990) . The use of wine as a medicine, or as a carrier for medications, has a long history. It goes back at least to the ancient Egyptians . Ancient Greek and Roman society used wine extensively in herbal infusions. This practice continued largely unabated until the beginning of the twentieth century. The excessive abuse of distilled alcoholic beverages, combined with religious and political conservatism, created a backlash against all beverages containing alcohol, notably in North America. Alcohol was viewed as an agent of corruption to be annihilated. Following the failure of Prohibition, humans themselves, not alcohol, came to be viewed as the source of evil. Alcoholism is now appropriately viewed as a genuine disease, possessing a complex etiology (Nurnberger and Bierut, 2007) , with both genetic and environmental aspects. Thus, the social climate is changing, and the legitimate use of wine in medicine and health is being investigated seriously. Nevertheless, it is unlikely that doctors will soon be prescribing wine for its health benefi ts. Too often, people have a diffi culty recognizing the limits of rational use. Even dietary fl avonoid supplements (one of the benefi ts of wine consumption) may be detrimental if taken in excess (Skibola and Smith, 2003) . Alcohol is the primary by-product of fermentative metabolism in many organisms. Ethanol is also an energy source for an even larger number of species. Thus, it is not surprising that enzymes involved in ethanol oxidation are found in most life forms, including humans. In humans, ethanol enters the bloodstream either via the consumption of beverages containing alcohol, or from ethanol synthesized by the bacterial fl ora in the intestinal tract. When the concentration of alcohol is low, most of it is metabolized in the liver before it enters the systemic blood fl ow. Most of the blood supply from the digestive tract passes through the liver before dispersing to the rest of the body. The liver metabolizes about 95% of alcohol in the plasma, at about 15 ml/h. The rest of the alcohol tends to be lost in the breath, or secreted in the urine and other bodily fl uids. The liver possesses two enzymic pathways for ethanol metabolism. The primary (constitutive) mechanism involves the oxidation of ethanol to acetaldehyde, through the action of cytoplasmic alcohol dehydrogenases (ADHs). Of the seven known ADH genes, three function in the liver. The others act in the gastric epithelium and other tissues. Subsequent oxidation converts acetaldehyde to acetic acid. This occurs principally under the action of mitochondrial acetaldehyde dehydrogenase (ALDH2). Cytoplasmic acetaldehyde dehydrogenase (ALDH1) is less active. The acetic acid may be released into the blood or converted to acetyl CoA. From this point, metabolism may fl ow along any of the standard biochemical pathways (Fig. 7.15 ). As noted, alcohol metabolizing enzymes frequently occur in allelic forms (isozymes). Their relative occurrence also tends to vary among ethnic groups. Some of the isozymes possess distinct physiological attributes. For example, ADH1B*1 codes for an isozyme that oxidizes ethanol slowly, whereas ADH1B*3 encodes for a highly active version (about 30 times more efficient) (Thomasson et al., 1995) . These allelic variants are common among African Americans. Fast and slow acting isozymes of ADH1C are common in Europeans. Rapid alcohol oxidation may donate a degree of protection against alcoholism, by quickly converting ethanol to acetaldehyde. Such individuals tend to drink less and show more rapid and marked negative consequences to alcohol consumption than do those metabolizing alcohol more slowly (Wall et al., 2005) . However, this probably reduces some of the health benefi ts of ethanol consumption. The effect of mutants of mitochondrial acetaldehyde dehydrogenase gene (ALDH2) is discussed below. A second metabolic routing of ethanol metabolism occurs only when the blood alcohol concentration is high. It entails an inducible pathway involving microsomal cytochrome P4502E1. It oxidizes ethanol to acetaldehyde, using molecular oxygen rather than NAD ϩ . The activation of the microsomal oxidation pathway has the undesirable side-effect of generating free oxygen radicals (Meagher et al., 1999) . The free-radical activity can remain long after alcohol intake has ceased. Although most free oxygen radicals are inactivated by glutathione, superoxide dismutase, and catalase, long-term exposure to trace amounts of oxygen radicals may induce the slow, progressive accumulation of irreparable cellular damage. Subsequent oxidation of acetaldehyde, generated by the microsomal pathway, to acetic acid is identical to that derived by alcohol dehydrogenase. The metabolism of ethanol to acetate (acetic acid) has the advantage that tissue cells can regulate its transport. This is not true for ethanol, which can diffuse freely across cellular membranes. Control of transport is central to proper cellular function. The ability of ethanol to displace water, and its unregulated passage cross cell membranes, explains much of alcohol's cytoplasmic toxicity. In addition, its oxidation to acetaldehyde is more rapid than the subsequent oxidation to acetate. Thus, acetaldehyde may accumulate in the blood and other bodily fl uids. This is often viewed as an important contributor to the toxicity associated with excessive alcohol consumption. Differentiating between the direct and indirect toxic effects of excessive ethanol intake has proven diffi cult. One of the fi rst physiologic effects of alcohol consumption is a suppression of higher brain function. This is most noticeable in enhanced sociability -by blocking social inhibitions. For others, it quickly induces drowsiness (Stone, 1980) . This probably explains why taking a small amount of wine (90-180 ml) before bed often helps people, notably the elderly, suffering from insomnia (Kastenbaum, 1982) . Half a glass of wine provides the benefi ts of sleep induction, without causing agitation and sleep apnea -often associated with greater alcohol consumption. The effect on sleep may arise from alcohol facilitating the transmission of inhibitory γ-aminobutyric acid (GABA), while suppressing the action of excitatory glutamate receptors (Haddad, 2004) . GABA and glutamate are estimated to be involved in about 80% of neuronal circuitry in the brain. Another effect on brain function results from a reduction in hormonal secretion -notably vasopressin. As a consequence, urine production increases, producing the diuretic effect frequently associated with alcohol consumption. Less well known is how alcohol acts as a crucial regulator of the hypothalamic-pituitary-adrenal axis, modulating the release of hormones such as adrenocorticotropic hormone (ACTH) and corticosterone (Haddad, 2004) . Although alcohol has a general depressive action on brain function, the levels of some brain modulators show transitory increases. Examples are serotonin and histamine. The latter may activate a cascade of reactions leading to headache production. Another of the multiple infl uences of alcohol is the conversion of hepatic glycogen to sugar. This results in a short-lived increase in plasma glucose content. This, in turn, can cause glucose loss in the urine, as well as an increase in insulin release by the pancreas. Both result in a drop in blood sugar content. If suffi ciently marked, hypoglycemia results. This apparently causes the temporary weakness often associated with excessive alcohol intake. In addition to the direct effects of ethanol, the accumulation of acetaldehyde may have several undesirable consequences. It may be involved in much of the chronic damage associated with alcoholism. At low rates of alcohol intake, acetaldehyde metabolism is suffi ciently rapid to limit its accumulation and liberation from the liver. At higher concentrations, acetaldehyde rapidly consumes glutathione reserves in the liver -an crucial cellular antioxidant. This coincides with activation of the microsomal ethanol oxidation pathway that generates toxic free-oxygen radicals. In the absence of suffi cient glutathione, free-oxygen radicals can accumulate, disrupting mitochondrial function. Elsewhere in the body, acetaldehyde can bind with proteins and cellular constituents, forming stable complexes (Niemela and Parkkila, 2004) . These can lead to the production of immunogenic determinants, which can stimulate antibody production against acetaldehyde adducts. This may generate some of the chronic tissue damage associated with alcohol abuse (Niemela and Israel, 1992) . The binding of acetaldehyde to the plasma membrane of red blood cells is known to increase their rigidity. By limiting their ability to squeeze through the narrowest capillaries, oxygen supply to tissue cells may be restricted. This could participate in suppressed brain function. Nerve cells show only respiratory (oxygen-dependent) metabolism. It is estimated that the brain consumes up to 20% of the blood's oxygen supply. Although ethanol and acetaldehyde can produce severe, progressive, and long-term damage to various organs, and incite alcohol dependence, these consequences are absent when alcohol consumption is moderate and taken with meals. As the sections below demonstrate, moderate, daily, wine consumption has clear health benefi ts for the majority of people. Wine's major nutritional value comes from the rapidly metabolized, caloric value of its ethanol content. Alcohol does not need to be digested, and can be absorbed directly through the intestinal wall. In rural viticultural areas, wine historically functioned as a major source of metabolic energy for the adult population. Wine in those regions was a food. Wine contains small quantities of several vitamins, notably the B vitamins, such as B 1 (thiamine), B 2 (ribofl avin), and B 12 (cobalamin). However, wine is virtually devoid of vitamins A, C, D, and K. In excess, ethanol can impair vitamin uptake. Wine contains various minerals in readily available forms, especially potassium and iron (in the ferrous state). Nevertheless, excessive alcohol consumption can disturb the uptake of calcium, magnesium, selenium, and zinc, and increase the excretion of zinc via the kidneys. The low sodium/high potassium content of wine makes it one of the more effective sources of potassium for individuals on diuretics. Although wine contains soluble dietary fi ber, especially red wines (Díaz-Rubio and Saura-Calixto, 2006) , it is insuffi cient to contribute signifi cantly to the daily recommended fi ber content in the human diet. Wine has several direct and indirect effects on food digestion. The phenolic (Hyde and Pangborn, 1978) and alcohol (Martin and Pangborn, 1971 ) contents of wine activate the release of saliva. In addition, wine promotes the release of gastrin as well as gastric juices. Succinic acid is the principal wine ingredient activating the release of gastric juices (Teyssen et al., 1999) . It does not, however, activate gastrin release. The substance(s) involved in stimulating gastrin secretion are unknown. Wine also signifi cantly delays gastric emptying, both on an empty stomach (Franke et al., 2004) , or when consumed with food (Benini et al., 2003) . The latter favors digestion by extending acid hydrolysis. It also promotes inactivation of pathogenic food contaminants. In addition, wine slows plasma glucose uptake, independent of any insulin response (Benini et al., 2003) . Furthermore, at the levels found in most table wines, ethanol activates the release of bile in the intestines. Wine acids and aromatics also induce the same effects. In contrast, the high alcohol content of distilled beverages can suppress digestive juice fl ow, the release of bile, and induce stomach spasms. Despite the general benefi cial effects of alcohol on digestion, the phenolic content of red wine may retard digestion. For example, tannins and phenolic acids interfere with the action of certain digestive enzymes, such as α-amylase, lipase and trypsin (Rohn et al., 2002) . Digestion may be further delayed by polymerization between tannins and food proteins. Although potentially delaying digestion in the small intestine, it continues in the colon. In contrast, some phenolics, such as quercetin, resveratrol, catechin, and epigallocatechin gallate, promote pepsin-activated protein breakdown (Tagliazucchi et al., 2005) . The phenolic content of wine also decreases the intestinal absorption of iron and copper. Although this may be undesirable by limiting the bioavailability of iron under defi ciency conditions, it has the benefi t of reducing the formation of toxic lipid hydroperoxides during digestion in the intestines. The antioxidant effect of polyphenolics also applies to hydroperoxide generated in the stomach (Kanner and Lapidot, 2001) . Wine also has a cultural/psychologic effect on digestion. The association of wine with refi ned eating promotes slower food consumption, permitting biofeedback mechanisms to induce satiety and regulate food intake. In addition, wine consumption can promote a more relaxed lifestyle, something increasingly valuable in our overly compulsive society. Whether this explains the improved appetite of many elderly and anorectic patients when wine is taken with the meal is unknown. The activation of gastric juice release not only aids food digestion, but also inactivates enzymes involved in ulceration. Even more signifi cant may be the antibiotic action of wine constituents on Helicobacterium pylori (Fugelsang and Muller, 1996) . H. pylori is considered the primary cause of stomach ulceration. Moderate wine consumption appears have a prophylactic effect limiting ulcer initiation (Brenner et al., 1997) . The bacterium is also implicated in gastritis, vitamin B 12 malabsorption, and gastric adenocarcinoma. Wine may further aid human sustenance by increasing nutrient uptake. Congeners combine with metallic ions, vitamins, and fatty acids, facilitating their transport across the intestinal wall. Finally, consuming wine with food slows the rate of alcohol uptake in the blood ( Fig. 12.1 ). In the absence of food, about 80% of alcohol absorption occurs through the intestinal wall. This value increases in the presence of food. By retarding gastric emptying, food consumption slows the transfer of alcohol into the intestine. This extends the period over which the liver can metabolize ethanol. The result is a reduction in the maximal alcohol content reached in the blood. However, taking sparkling wine on an empty stomach increases shortterm alcohol uptake by about 35% (Ridout et al., 2003) . Although the cause of the difference is unknown, it is suspected that carbon dioxide relaxes the pyloric sphincter, allowing earlier transfer of fl uids from the stomach into the duodenum. The rate of alcohol metabolism differs considerably among individuals, with rates commonly varying between 90 and 130 mg/kg/h. The hormonal and nutritional state of the individual can affect the rate of ethanol metabolism. To fully understand the signifi cance of wine phenolics to health, it will be necessary to know the dynamics of their uptake, concentration, metabolism, and elimination. Such data are just now starting to become available. In the mouth, mid-sized fl avonoid polymers often bond to salivary proteins, forming stable complexes (De Freitas and Mateus, 2003; Pizarro and Lissi, 2003) . This signifi cantly limits their uptake in the stomach and small intestine. Passage through the stomach does not modify the majority of wine phenolics. Nevertheless, fl avonoids such as anthocyanins quickly traverse the stomach and pass into the blood (Passamonti et al., 2003) . They are also effectively translocated across the wall of the small intestine (Talavéra et al., 2005) . Phenolic acids, such as caffeic acid (Simonetti et al., 2001) and resveratrol (Soleas et al., 2001) also readily pass into the plasma via the intestinal tract. In contrast, polymers tend to remain in the intestine until degraded by bacteria in the colon (Scalbert et al., 2002) . A small portion of their breakdown products, primarily phenolic acids, are subsequently absorbed into the blood via the colon (Ward et al., 2004) . Studies on the bioavailability of fl avonoids in the blood are in their infancy (Williamson and Manach, 2005) . Although many fl avonoids are quickly absorbed into the plasma, most appear to be rapidly conjugatedbeing methylated, sulfated, transformed to glucuronsides, or otherwise metabolized (see Williams et al., 2004) . These transformations could signifi cantly affect their antioxidant and other properties, as well as their ability to move into tissues. Most of these metabolites still retain a reducing phenolic group, and, thus, may possess antioxidant properties. Nevertheless, there is growing evidence that phenolic metabolites act primarily as signaling molecules, notably in oxygen-stressrelated pathways (Williams et al., 2004) . Smaller amounts of chemical are needed for signaling reactions, than direct antioxidant effects. This might explain the discrepancy between the low levels of free phenolics in the plasma and their apparent effects in the body. Future studies will have to investigate the effi cacy of phenolic metabolites and conjugated complexes, at concentrations found in the plasma. Their effi cacy at binding to, or translocation into tissue cells, is little known. Survival of most of these constituents in the plasma is comparatively short (a few hours). Breakdown products of phenolic metabolism rapidly appear in urine shortly after uptake in the plasma. Presence in the plasma probably permits their diffusion into most body tissues. This does not apply to the brain. Except where there are specifi c transport proteins, most compounds above a molecular weight of 500 Da are excluded by the blood-brain barrier. This barrier exists due to tight connections between the endothelial cells that makeup the lining of cerebral capillaries. This prevents the diffusion of molecules between vascular endothelial cells that is typical elsewhere in the body. However, with anthocyanins (Passamonti et al., 2005) and simple fl avonols (Youdim et al., 2004) , access to the brain occurs within minutes of consumption. The prophylactic action of wine against gastrointestinal infections has been known for millennia, long before the microbial nature of infectious diseases was suspected. This action is complex and not fully understood. The antimicrobial effect of alcohol was discovered in the late 1800s. Nevertheless, alcohol is not particularly antimicrobial at the concentrations found in wine (optimal at about 70%). Thus, the antibiotic action of wine results primarily from other constituents, probably its phenolic content. Modifi cation of anthocyanins during fermentation increases their toxicity to viruses, protozoans, and bacteria. Other phenolic compounds commonly found in red wines are also bacteriostatic and fungistatic. For example, p-coumaric acid is particularly active against gram-positive bacteria, such as Staphylococcus and Streptococcus, whereas other phenols inhibit gramnegative bacteria, for example Escherichia, Shigella, Proteus, and Vibrio (Masquelier, 1988) . The latter cause serious forms of diarrhea and dysentery. Despite wine being more effective than antimicrobial agents, such as bismuth salicylate (Weisse et al., 1995) , full action may take several hours (Møretrø and Daeschel, 2004; Dolara et al., 2005) . In most instances, the mechanism by which phenolics have their action is unknown. However, in the case of quercetin, the effect may be partially attributed to its inhibition of DNA gyrase, whereas with epigallocatechin, disruption of cell membrane function appears central to its antibiotic action. The low pH and presence of various organic acids appear to accentuate the antimicrobial action of both wine phenolics and ethanol. It is not without good reason that Roman armies added wine or vinegar to their drinking water. Diarrhetic soldiers do not win wars. Wine is also active against several viruses, including the herpes simplex virus, poliovirus, hepatitis A virus, as well as rhinoviruses and coronaviruses. The effect on the latter two groups appears refl ected in the reduced incidence of the common cold in moderate alcohol consumers (Cohen et al., 1993) , particularly those drinking red wines (Takkouche et al., 2002) . If you have to gargle, port is certainly one of the more pleasant options available. The most clearly established benefi t of moderate alcohol consumption, notably wine, relates to a nearly 30-35% reduction in death rate due to cardiovascular disease (Klatsky et al., 1974 (Klatsky et al., , 2003 Renaud and de Lorgeril, 1992) . Figure 12 .2 provides an example of such results. Alcohol consumption also decreases the likelihood of intermittent claudication (pain or cramping in the calf of the leg). Claudication is a common indicator of peripheral arterial disease. Recent studies have confi rmed that incidental factors, such as gender, race, lifestyle, educational level, etc. do not affect the results (for example, Mukamal et al., 2006) . Studies have also demonstrated that daily consumption of alcohol signifi cantly reduces the incidence of other forms of cardiovascular disease, such as hypertension (Keil et al., 1998) , heart attack (Gaziano et al., 1999) , stroke (Truelsen et al., 1998; Hillbom, 1999) , and peripheral arterial disease (Camargo et al., 1997) . Those who consume wine moderately live, on average, 2.5-3.5 years longer than teetotalers, and considerably longer than heavy drinkers. The prime area of contention is the degree to which these benefi ts accrue from the effects of ethanol vs. phenolic constituents (Rimm et al., 1996) . Atherosclerosis is the principal cause of most cardiovascular disease (Libby, 2001) . It apparently results from chronic injury to the arteries ( Fig. 12. 3). Although associated with several independent factors, most damage develops as a result of the oxidation of lipids in a special subgroup of cholesterol-apoproteins complexes, the lowdensity lipoproteins (LDLs). Because of the hydrophobic nature of cholesterol and triglycerides, their transfer via the blood requires a special transport vehicle. As illustrated in Fig. 12 .4, lipoprotein complexes consist of an outer membrane of phospholipids, in which apoproteins and free cholesterol occur. They enclose a hydrophobic core possessing numerous triglycerides and cholesteryl esters. The specifi c apoproteins in the complex regulate the metabolism of the associated lipids. Normally, LDLs function in supplying cholesterol for cellular membrane repair and the synthesis of steroids. However, in high concentrations, they may accumulate in the artery wall. If they remain there for an extended period, their lipid content tends to become oxidized. In an oxidized form, lipids are cytotoxic and indirectly irritate the artery wall. As a consequence, special adhesion proteins attach to the artery wall. Monocytes and helper T-cells of the immune system bond to these proteins. In addition, affected endothelial cells may secrete compounds, such as endothelin-1. Endothelin-1 activates (From Walzem and Hansen, 1996, reproduced by permission) the migration of monocytes and T-cells into the artery wall. Procyanidins, principally found in red wines, are particularly effective in suppressing the production of endothelin-1 (Corder et al., 2001) . In the layer just underneath the endothelial lining (intima), monocytes mature into macrophages. Both macrophages and T-cells may release cytokines that further activate the immune system, involving localized infl ammation. Activated macrophages tend to engulf oxidized LDLs. However, as the LDLs are not degraded, their progressive accumulation gives the macrophage the appearance of being full of bubbles. This has given rise to the term foam cells. They are the fi rst clear evidence of the beginning of localized arterial swelling (plaques). Occasionally plaques enlarge inward, but more frequently they bulge outward into the surrounding tissue. Action of immune cells in the plaque also induces migration of smooth muscle cells from the artery wall into the intima. Here they proliferate and produce collagen, forming a fi brous cap over the plaque. Additional LDLs slowly collect, provoking further rounds of infl ammation and enlargement of the plaque. These accretions may develop their own vasculature, becoming fi brous and inelastic. As the plaques enlarge, they may produce irregular protrusions into and block the artery lumen. Even without restricting blood fl ow, plaques set the stage for platelet aggregation, clot formation (thrombus) and the blockage that can precipitate a heart attack or stroke. In the later phases of plaque formation, unknown factors enhance infl ammatory changes in the plaque. These disrupt the integrity of the cap. For example, collagenases secreted by macrophages inhibit collagen synthesis by smooth muscle cells. Sudden rupture of a plaque permits blood infi ltration into the plaque. Because plaques contain potent blood clotting factors, thrombus development is almost instantaneous. It is currently thought that plaque rupture is the principal factor inducting thrombus formation, and precipitating a heart attack, stroke, or other cardiovascular trauma. If the risk factors of atherosclerosis, such as smoking, high blood pressure, high dietary sources of cholesterol, and possibly infection by pathogens such as Chlamydia pneumoniae and cytomegalovirus (CMV) are eliminated, atherosclerosis appears to be at least partially reversible. Part of the reversal process involves the action of high-density lipoproteins (HDLs). Of the two principal forms, ethanol augments the presence of HDL 3 , whereas exercise increases the level of HDL 2 . Either form tends to remove cholesterol from the arteries, transferring it to the liver for metabolism. HDLs also appear to interfere with LDL oxidation. The effect of ethanol on HDL concentration appears to be independent of beverage type (van der Gaag et al., 2001) . The slower the rate of LDL turnover, the greater the likelihood of oxidation (Walzem et al., 1995) . The benefi cial effect of moderate alcohol consumption on the HDL/LDL ratio is now clearly established. Less well understood is its effect in lowering the concentration of C-reactive protein (CRP) (Levitan et al., 2005) . CRP is an indicator of infl ammation. Moderate alcohol consumption also reduces the incidence of another risk factor for cardiovascular diseasetype 2 diabetes. Chronically high values of circulatory glucose, associated with type 2 diabetes, appear to generate high plasma triglyceride and LDL levels. The benefi cial effects of alcohol on glucose and insulin metabolism appear not to occur if intake is not coincident with meal consumption (Augustin et al., 2004) . Phytoestrogens, such as resveratrol, have a similar effect in reducing triglyceride and LDL contents in the circulatory system (see Bisson et al., 1995) . Another of alcohol's benefi cial infl uences involves disruption of events leading to clot formation. Platelets are less 'sticky' in the presence of alcohol, thus, less likely to aggregate to form a clot. Alcohol also increases the level of prostacyclin (interferes with clotting) and raises the level of plasminogen activator (a clot-dissolving enzyme). Clots adhering or becoming stuck to the roughened surfaces of narrowed atherosclerotic vessels may block blood fl ow. The oxygen defi ciency and cell death that result are central to the damage caused by a heart attack or stroke. Thus, it is not surprising that inhibitors of platelet aggregation reduce the frequency of these cardiovascular crises. It is the rationale for recommending the daily consumption of acetylsalicylic acid (ASA) (an inhibitor of platelet aggregation). Ethanol (Renaud and Ruf, 1996) , as well as wine phenolics, such as resveratrol and anthocyanins, have similar effects (Fig. 12.5 ). An additional example of the importance of ethanol in cardiovascular disease is the correlation between alcohol dehydrogenase (ADH) genotype and the incidence of myocardial infarction. Those individuals homozygous for ADH1C*2 (slow metabolizers of ethanol) are signifi cantly less likely to have a heart attack than heterozygous individuals, and even less likely than homozygous individuals for ADH1C*1 (fast metabolizers of ethanol) (Hines et al., 2001) . Individually, many phenolics, such as resveratrol, catechin, epicatechin, and quercetin, have inhibitory effects on platelet aggregation (Keli et al., 1994) . Nevertheless, the combined effect of several phenolics is superior to single compounds (Wallerath et al., 2005) . The action partially results from the enhanced synthesis and release of nitric oxide by endothelial cells. Nitric oxide induces vasodilation (by relaxing vascular smooth muscle), and limits platelet adhesion to blood vessel endothelia. Indicative of the complexities of such interactions is the observation that fl avonoids may also inactivate nitric oxide (Verhagen et al., 1997) . In addition, nitric oxide, notably as peroxynitrile, oxidizes LDLs. In addition to effects on platelet aggregation, phenolic wine constituents bind directly with LDLs (limiting their oxidation), indirectly reduce macrophage-mediated oxidation of LDLs, and preserve the action of paraoxonase (further protecting LDLs from oxidation) (Aviram and Fuhrman, 2002) . Furthermore, red wine phenolics limit the migration of smooth muscle cells into the intima of artery walls. These infl uences probably explain some of the added benefi ts of wine versus other alcoholic beverages in reducing the incidence and severity of cardiovascular disease. Although fl avonoids tend to suppress infl ammation, confl icting observations put the clinical signifi cance of their anti-infl ammatory action to atherosclerosis in question. Red wines usually have been credited with superior benefi ts to white wines, relative to cardiovascular disease. This probably results from their higher fl avonoid concentration. This view is supported from studies where white wine has shown the same effects as red wine when supplemented with grape polyphenolics (Fuhrman et al., 2001) . Nevertheless, prolonged skin contact, or choice of particular cultivars, can enhance the presence of phenolic acids in white wines. Common phenolics in white wine, such as caffeic and coumaric acids, as well as fl avonols, such as quercetin, are well-known, potent antioxidants. The low sodium content of wine is an incidental benefi t. It may permit wine consumption by those on a low-sodium diet, for example heart attack victims. The high potassium to sodium ratio of wine (20 : 1) is a further benefi t. Wine phenolics are not only important antioxidants in wine preservation, but also play a role as antioxidants in the human body. By limiting LDL peroxidation (Maxwell et al., 1994; , they restrict one of the critical early stages of atherosclerosis. This probably results from the inhibition of lipoxygenases, as well as the scavenging of free oxygen radicals, such as superoxide and hydroxyl radicals, and by chelating iron and copper (involved in radical formation) (Morel et al., 1994; . In addition, tannin subunits (catechins and epicatechins) appear to protect other cellular components from oxidation. Other antioxidants of importance in the human diet are vitamins E and C (tocopherol and ascorbic acid), β-carotene, and selenium. The occurrence of tocopherol in the precursor of LDLs may provide a natural, but short-term, protection from oxidation. One of the antioxidants relatively unique to wine is resveratrol. It is a phenolic (stilbene) compound produced in response to fungal attack or other stresses. Other plants producing resveratrol include mulberries, blueberries, peas, and peanuts. It has greater antioxidant action than dietary antioxidants such as vitamin E and ascorbic acid (Frankel et al., 1993) . There is also direct evidence that resveratrol can enter the blood system at levels suffi cient to suppress cyclooxygenase (COX) and 5-lipoxygenase pathways. These are involved in the synthesis of proinfl ammatory mediators (Bertelli, 1998) . In addition, resveratrol activates proteins involved in nerve cell differentiation, synaptic plasticity (important in learning), and neuronal survival (Tredici et al., 1999) . Additional potent antioxidants in wine are fl avonols, such as quercetin, and fl avonoid tannin subunits (Miller and Rice-Evans, 1995) . Flavonoids have been shown to possess various mechanisms of action, some directly quenching free radicals, others increasing the level of endogenous antioxidants, such as glutathione, whereas others prevent the infl ux of calcium ions associated with oxidative stress (Ishige et al., 2001) . They may also be more effective antioxidants, as well as occurring at higher concentrations, than resveratrol. Their content depends partially on the duration of skin contact and the type of fi ning. For example, PVPP (polyvinylpolypyrrolidone) markedly reduces quercetin content (Fluss et al., 1990) . Alternately, de la Torre et al. (2006) have suggested that ethanol itself may modify human metabolism, increasing the synthesis of hydroxytyrosol. The latter is a well-known antioxidant phenolic found in olive oil. Consumption of red wine, with a concentration of 0.35 mg hydroxytyrosol, increased the concentration of hydroxytyrosol in the blood more than administration of olive oil, at a concentration of 1.7 mg hydroxytyrosol. Many of the benefi cial infl uences of alcohol and wine consumption show a U-shaped curve. This also applies to its effect on age-related macular degeneration (Obisesan et al., 1998; Fraser-Bell et al., 2006) . The disease expresses itself as a progressive degeneration of the central region of the retina (macula) that leads to blurred or distorted vision. It results as a consequence of local atherosclerosis that deprives the retina of oxygen and nutrients. It is the leading cause of blindness in adults over the age of 65. A similar relationship has been found for cataract development. In both situations, wine antioxidants are suspected to be the active protective agent. At higher rates of intake, ethanol promotes a prooxidant action that could negate the benefi ts of wine antioxidants. Alzheimer's is one of the most investigated of neurodegenerative diseases, affecting approximately 15 million people worldwide. It is not surprising that researchers have investigated whether wine consumption reduces the incidence of neurodegenerative diseases affected by oxidative stress (Barnham et al., 2004) . A pattern appears to apply here, as with so many other health-related benefi ts of wine and alcohol consumption. Moderate intake is benefi cial, whereas heavier consumption or abstinence is prejudicial. Alzheimer's disease is associated with the accumulation of extracellular amyloid β-peptide (plaque), and the formation of intracellular neurofi brillar tangles containing tau-protein. The latter supports microtubule cytoplasmic structures. Many in vitro studies have shown that antioxidant compounds, such as vitamin E, protect neurons from β-amyloid accumulation. Tannic acid has also been shown to inhibit the formation of, and destabilize preexisting β-amyloid fi brils (Ono et al., 2004) , whereas resveratrol promotes the degradation of amyloid β-peptides (Marambaud et al., 2005) . Wine consumption is also linked in epidemiological studies to a reduction in the incidence of Alzheimer's disease (Truelsen et al., 2002; Letenneur, 2004; Luchsinger et al., 2004) . Even mild cognitive impairment and the progression of idiopathic dementia may be reduced with moderate alcohol consumption (Solfrizzi et al., 2007) . Like other health benefi ts, these fi nding may not, in themselves, justify wine consumption, but they are encouraging to those who choose wine as part of their preferred lifestyle. Age-related loss in bone mass affects both sexes, but is particularly prominent in postmenopausal women. Many risk factors, dietary infl uences, and hormonal supplements can affect its occurrence and severity. Of these factors, moderate alcohol consumption has been found to favor bone retention (Ganry et al., 2000; Ilich et al., 2002) . These studies did not separate between various alcoholic beverages, thus, whether bone retention is due to enhanced calcium uptake associated with alcohol consumption (Ilich et al., 2002) , the phytoestrogen effects of phenolics, such as resveratrol, or some other infl uence is unknown. In the 1800s, there were many reports linking gout with wine consumption, especially port. Gout is caused by the localized accumulation of uric acid crystals in the synovium of joints. Their presence stimulates the synthesis and release of humoral and cellular infl ammatory mediators (Choi et al., 2005) . Gout is often associated with reduced excretion of uric acid in the kidneys. Mutations in the gene that encodes urease, the enzyme that metabolizes uric acid to allantoin (a soluble byproduct), is often involved in gout. Dietary predisposing factors include red meat, seafood, and beer -presumably due to the increased availability of purines, the principal source of uric acid. Alcohol consumption may occasionally aggravate gout by increasing lactic acid synthesis. It, in turn, favors uric acid reabsorption by the kidneys. Despite this, wine consumption has not been found to be associated with an increased risk for gout (Choi et al., 2004) . Medical historians suspect the gout-port connection in the nineteenth century was associated with leadinduced kidney damage (Yu, 1983; Emsley, 1986 Emsley, /1987 . Samples of port from the nineteenth century show high lead contents. Lead contamination probably came from its uptake from stills, used in making the brandy added in port production. In addition, the former use of pewter and lead-glazed drinking cups, and prolonged storage of port in lead crystal decanters, could have further augmented the lead content (Falcone, 1991) . A number of drugs used in treating arthritis have a tendency to irritate the lining of the stomach. This sideeffect may be counteracted by the mildly acidic, dilute alcohol content of table wines. Other benefi cial effects connected with moderate wine consumption may accrue from its mildly diuretic and muscle-relaxant properties. The diuretic action of wine can help reduce water retention and minimize joint swelling. Wine can also directly reduce muscle spasms and the stiffness associated with arthritis. The antiinfl ammatory infl uences of wine phenolics, notably resveratrol, may also play a role in diminishing the suffering associated with arthritis. Wine consumption has been shown to attenuate insulin-resistance in type 2 diabetes (Napoli et al., 2005) . This may result from wine phenolics quenching oxygen radicals, thought to be pivotal in the damage associated with type 2 diabetes. Type 2 diabetes appears to result when body cells do not respond properly to the presence of insulin. Moderate alcohol consumption is also associated with reduced incidence of this form of diabetes (Dixon et al., 2001) . The incidence of metabolic syndrome X is also lower in wine drinkers (Rosell et al., 2003) . These effects may be due to one or more of the following: the infl uences of alcohol on metabolism; the antidiabetic properties of the element vanadium (of which wine is a signifi cant source) (Brichard and Henquin, 1995; Teissèdre et al, 1996) ; the hypoglycemic and hypolipidemic effects of phenolics like resveratrol (Su et al., 2006) ; or through some effect on endothelial nitric oxidase synthase (Leighton et al., 2006) . Moderate consumption of dry wine has no adverse effect on sugar control in diabetic patients (Gin et al., 1992; Bell, 1996) . In an epidemiological study, Knudsen et al. (2001) found a strong link between alcohol consumption and a reduced prevalence of goitre and solitary thyroid nodules. This effect may result from some unknown protective effect of ethanol. Drinking water has long been associated with reducing the development of kidney stones. Increased urine production helps prevent the crystallization of calcium oxalate in the kidneys. What is new is the observation that wine consumption further reduces the production of these painful and dangerous inclusions (Curhan et al., 1998) . The consumption of moderate amounts of wine has not been shown to increase the incidence of most cancers. In contrast, increased consumption tends to increase the risk of certain cancers (see Ebeler and Weber, 1996) . In certain instances, these infl uences may derive from indirect effects on carcinogens, such as ethyl carbamate. At the concentrations typically found in table wine, though, ethanol diminishes the carcinogenesis of ethyl carbamate. Certain wine phenolics can be protective, whereas others can be mutagenic, especially at high concentrations. For example, quercetin can induce mutations in laboratory tissue culture, but is a potent anticarcinogen in whole-animal studies (Fazal et al., 1990) . This apparent anomaly may result from differences in the concentrations of quercetin used, and the low level of metal ions and free oxygen found in the body (vs. tissue culture). In addition, phenolics may detoxify the small quantities of nitrites commonly found in food. However, in the presence of high nitrite concentrations (a preservative found in smoked and pickled foods), nitrites are converted into diazophenols (Weisburger, 1991) . These can induce oral and stomach cancers. Several phenolics can limit or prevent cancer development through a diversity of effects, such as DNA repair, carcinogen detoxifi cation, enhanced apoptosis (programmed cell death), and disrupted cell division (Hou, 2003; Aggarwal et al., 2004) . For example, resveratrol induces the redistribution of the Fas receptor. It is a site for the attachment of TNF (tumor necrosis factor) in colon cancer. Its action is part of a sequence that leads to the death of the affected cancer cells (Delmas et al., 2003) . Resveratrol is also well known as an inhibitor of angiogenesis -the production of new vasculature essential for tumor growth. Other effects of resveratrol include inhibition of cyclooxygenase-2 (Subbaramaiah et al., 1998) and P450 1A1 (Chun et al., 1999) . Cyclooxygenase-2 is thought to be involved in carcinogenesis, whereas P450 1A1 is an important hydroxylase. It can convert several environmental toxicants and procarcinogens into active carcinogens. Flavones and fl avonols strongly restrict the action of the common dietary carcinogens, heterocyclic amines (Kanazawa et al., 1998) . It is estimated that these compounds, produced during cooking, are consumed at a rate of approximately 0.4-16 μg per day (Wakabayashi et al., 1992) . The antiallergic and antiinfl ammatory properties of fl avonoid phenolics probably also contribute to the anticancer aspects of these fl avonoids (see Middleton, 1998) . The major exception to the general benefi t of moderate wine consumption against cancer may be breast cancer (Viel et al., 1997) . This correlation is more evident in those with the ADH1C*1 (fast metabolizers of ethanol to acetaldehyde, a known carcinogen) (Terry et al., 2006) . However, fi ndings from the long-duration Framingham Study indicate no relationship between moderate alcohol consumption and the incidence of breast cancer (Zhang et al., 1999) . High rates of wine consumption have been linked with an increased incidence of mouth and throat cancers (Barra et al., 1990) . Ethanol itself is not carcinogenic, but can enhance the transforming effect of some carcinogens. Alcoholic beverages may induce a wide diversity of allergic and allergic-like reactions. In sensitive individuals, these may express as rhinitis, itching, facial swelling, headache, cough, or asthma. Occasionally, ethanol plays a role in these responses, for example the fl ushing reaction of many Asians. Nevertheless, sulfur dioxide is potentially the most signifi cant wine irritant. A small proportion of wine-sensitive asthmatics may experience bronchial constriction on exposure to sulfi te (Dahl et al., 1986) . In a study by Vally and Thompson (2001) , wine containing 300 ppm sulfi te induced a rapid drop in forced expiratory volume, reaching a maximal decline within about 5 min. Recovery took between 15 and 60 min. The same individuals did not respond to wine containing 20, 75, or 150 ppm sulfi te. Why sensitive asthmatics episodically react to wines with low SO 2 contents may be related to changes in the state of their asthma control. Surprisingly, red wines tend to provoke more asthma problems than white wines, even though red wines typically have lower sulfur dioxide contents than white wines. The speed of the reaction to sulfi te suggests some malfunction in the amount of glutathione in lung tissue, or the activity of glutathione S-transferase reducing sulfi te to glutathione S-sulfonate. Normally, sulfi te is rapidly converted to sulfate by sulfi te oxidase in the blood. However, low levels of this enzyme could permit sulfi te to persist, provoking a heightened response in hypersensitive individuals. At potentially greater risk are individuals affl icted with a rare autosomal genetic disease caused by a deficiency in sulfi te oxidase (Shih et al., 1977; Crawhall, 1985) . Affected individuals must live on a very restricted diet, low in sulfur-containing proteins. It is estimated that the synthesis of sulfi te, associated with normal food metabolism, generates approximately 2.4 g sulfi te/ day. The sulfi tes in wine contribute only marginally to this amount. Because of the gravity of sulfi te oxidase defi ciency, most affected people die before reaching adulthood. An intriguing allergy-like reaction is a rapid facial and neck fl ushing (cutaneous erythema) shortly after alcohol consumption. Other symptoms often include peripheral vasodilation, elevated heart rate, nausea, abdominal discomfort, and broncho-constriction. This reaction is found in up to 50% of eastern Asians. The syndrome is associated with a malfunctional form of mitochondrial acetaldehyde dehydrogenase (ALDH2) (Enomoto et al., 1991) . This is the principal enzyme oxidizing acetaldehyde to acetic acid. A malfunctional alcohol dehydrogenase allele (ADH1B) may also play a contributing role in the fl ushing reaction (Takeshita et al., 2001) . Elevated levels of acetaldehyde are thought to cause fl ushing by activating the localized release of histamine from mast cells. Histamine induces vasodilation and the associated infl ux of blood that appears as a reddening of the associated tissue. The connection between acetaldehyde and histamine is supported by the action of antihistamines in reducing this fl ushing, if taken in advance of an alcohol challenge (Miller et al., 1988) . Antihistamines can also diminish the rhinitis that may be associated with the consumption of red wine (Andersson et al., 2003) . In addition, antihistamines counteract the bronchoconstriction in individuals showing histamine intolerance. Histamine intolerance presumably relates to reduced activity of diamine oxidase . It has been suggested that the ALDH2 mutant in eastern Asians noted above may refl ect an evolutionary selective adaptation to the endemic occurrence of hepatitis B in that region of Asia (Lin and Cheng, 2002) . The resulting avoidance of alcohol would avert any synergism with hepatitis B-induced liver damage. Onset of a similar collection of unpleasant symptoms, associated with the abnormal accumulation of plasma acetaldehyde, is often used in the treatment of alcoholism. Disulfi ram (Antabuse) is a potent inhibitor of ALDH. Facial fl ushing, concomitant with alcohol consumption, but devoid of other symptoms, is occasionally experienced by Caucasians. Whether this is related to an ALDH malfunction is unclear. However, this possibility is supported by its suppression by acetylsalicylic acid (aspirin), if taken before an alcohol challenge (Truitt et al., 1987) . An alternative proposal is that the fl ushing results from a direct, cutaneous, alcohol-induced vasodilation. Idiosyncratic allergic and other immune hypersensitive responses to wine are diffi cult to predict or diagnose. Reactions may include the induction of headaches, nausea, vomiting, general malaise, or a combination of these. In a few instances, IgE-related anaphylaxis reactions have been reported to grape PR proteins (endochitinase and thaumatin) (Pastorello et al., 2003) . The reactions may involve urticaria/angiodema (red patches or wheals on the skin/swelling), and occasionally shock. Residual amounts of fi ning agents, such as egg whites, have also been implicated in some allergic reactions (Marinkovich, 1982) . However, in a double-blind, placebo-controlled trial, wines fi ned with egg white, isinglass, or non-grape derived tannins presented "an extremely low risk of anaphylaxis" to egg-, fi sh-, or peanut-allergic consumers (Rolland et al., 2006) . In an ELISA study, only egg white and lysozyme could be detected in wine samples (Weber et al., 2007) . Nevertheless, with more than 800 compounds potentially occurring in wine, it is not surprising that some individuals may occasionally show some form of adverse reaction to specifi c wines or wine types. In addition to physiological reactions to wine constituents, there is a wide range of equally important psychological responses (Rozin and Tuorila, 1993), both positive and negative. Traumatic memories associated with the fi rst exposure to, or excessive consumption of, a particular beverage can create an association that lasts a lifetime. Other people have come to associate certain products with social groups, lifestyles, or behaviors. Such attitudes can make the beverage unacceptable. People occasionally avoid wine consumption because it induces headaches. This situation has regrettably seen little study. Central to progress is effective differentiation of the multiplicity of headache phenomena and their specifi c etiologies. One of the most severe headache syndromes potentially associated with wine consumption is the migraine. Migraines may be induced by a wide range of environmental stimuli, possibly because migraines are themselves a complex of etiologically distinct events. The dilation of blood vessels in the brain, as a result of histamine release, can be the common element in many instances of headache development. When red vs. white wines were discovered to contain higher concentrations of biogenic amines, such as histamine and tyramine, there was the initial assumption that they were the culprits. However, it was later realized that the normal levels of histamine found in red wines are below those that generally trigger a migraine. In addition, double-blind studies have seemingly exonerated histamine in redwine-induced migraine headaches (Masyczek and Ough, 1983) . Nevertheless, alcohol can suppress the action of diamine oxidase, an important enzyme of the small intestine that inactivates histamine and other biogenic amines . Thus, in individuals with histamine intolerance, suffi cient histamine may enter the blood system to provoke a vascular headache. However, this view does not correlate with the observation that spirits and sparkling wine were more frequently associated with migraine attacks than other alcoholic beverages (Nicolodi and Sicuteri, 1999) . Both spirits and sparkling wines are low in histamine content. Although the biogenic amine content of wine appears to be insuffi cient to cause migraines in most individuals, the phenolic content of wine can induce headaches. Correspondingly, red wines are more frequently associated with headache production than white wines. On average red wines contain about 1200 mg/liter vs. 200 mg/ liter for whites. Some phenolics suppress the action of platelet phenolsulfotransferase (PST) (Jones et al., 1995) . Individuals having low levels of platelet-bound PST are apparently more susceptible to migraine headaches (Alam et al., 1997) . Suppression of PST results in reduced sulfation (detoxifi cation) of a variety of endogenous and xenobiotic ("foreign") compounds, including biogenic amines and phenolics. Without inactivation, biogenic amines can activate the liberation of 5-hydroxytryptamine (5-HT, or serotonin), an important neurotransmitter in the brain. 5-HT also promotes platelet aggregation and the dilation of small blood vessels in the brain. The pressure so created can cause intercranial pain, and the instigation of a migraine (Pattichis et al., 1995) . People prone to migraine headaches also may show abnormal and cyclical patterns in platelet sensitivity to 5-HT release (Jones et al., 1982; Peatfi eld et al., 1995) . This may be involved in why wine consumption is not consistently linked to headache induction. Small phenolic components in wine also prolong the action of potent hormones and nerve transmitters, such as histamine, serotonin, dopamine, adrenalin and noradrenaline. These could affect headache severity and other allergic reactions. In the treatment of the possibly closely related cluster-headache syndrome, small doses of lithium may be preventive (Steiner et al., 1997) . Because some red wines have higher than average lithium contents, they may prevent, rather than induce this type of headache. Another recognized headache syndrome is the red wine headache (Kaufman, 1986) . It may develop within minutes of consuming red wine and is often dose-related. The headache reaches its fi rst peak within approximately 2 hours, tends to fade, but returns roughly 8 hours later in a more intense form. The headache seems related to the release of type E prostaglandins, important chemicals involved in dilating blood vessels. If this association is correct, the inhibition of prostaglandin synthesis by acetylsalicylic acid, acetaminophen and ibuprofen could explain how these medications prevent headache development, when taken prior to wine consumption (Kaufman, 1992) . A distinct wine-related headache has been dubbed the red head (Goldberg, 1981) . It develops within an hour of waking, after drinking no more than two glasses of red wine the previous evening. The headache is associated with nausea. The headache is particularly severe when reclining. Although the headache is relieved somewhat by standing, this itself exacerbates the nausea. The headache usually lasts a few hours before dissipating. A similar phenomenon has been reported with some white wines, or mixtures of white wine, taken alone or with coffee or chocolates. Its chemical cause is unknown (Kaufman, 1986) . In most instances, headaches associated with wine consumption are assumed to be induced by tannins. However, tannins (polyphenolics) are poorly absorbed in the digestive tract. In contrast, their monomers are readily absorbed. This may explain why aged red wines (in which most tannins occur as large polymers) tend to be less associated with headache induction than their younger counterparts. A classic example is the ease with which the youngest of all red wines, Beaujolais nouveau, produces headaches in those prone to their occurrence. Large tannin polymers remain largely unmodifi ed until entering the colon, where bacteria metabolize them to low-molecular-weight phenolics (Déprez et al., 2000) . Because this can take up to two days, they cannot be involved in headache induction. However, headache induction may result from monomeric phenolics, such as caffeic acid and catechins. Depending on their metabolism in the plasma, phenolics may be detoxifi ed (o-methylated or sulfated), or made more 'toxic' (oxidized to o-quinones) . o-Quinones can inhibit the action of the enzyme catechol-O-methyltransferase (COMT). By so doing, the neurotransmitter dopamine is not broken down, and the availability of μ-opinoid (painkilling) receptors is restricted. Consequently, the perception of pain associated with cerebral blood vessel dilation may be enhanced. Resveratrol, a phenolic found in higher concentration in red than white wines, inhibits the expression of cyclooxygenases. Cyclooxygenase is involved in the synthesis of prostaglandins (Jang and Pezzuto, 1998) , dilators of cerebral blood vessels. This is another example of where some wine phenolics may counter, rather than induce headache development. In contrast, ethanol tends to elevate the concentration of prostaglandins (Parantainen, 1983) . The ability of some yeast strains to produce prostaglandins (Botha et al., 1992) introduces the intriguing possibility that prostaglandins may occur as constituents in wine. If produced in suffi cient quantity, yeast-derived prostaglandins could be another, or supplemental agent, involved in headache development. Yeast-derived prostaglandins could also theoretically provoke infl ammatory lung problems such as asthma. Although red wines are generally more associated with headache production than white wine, some headaches are exclusively associated with white table wines. Its characteristics and etiology are even less well understood than those evoked by red wines. In some individuals, this situation may be associated with a sensitivity to sulfi tes, which are generally found in higher concentrations in white wines than red wines, especially when young. One of the most recognized alcohol-related headache phenomena is that associated with binge drinking -the hangover (veisalgia) (Wiese et al., 2000) . Although not consistently associated with a headache, it is frequently an accompanying phenomenon. A hangover is characterized with tremulousness, palpitations, tachycardia, sweating, loss of appetite, anxiety, nausea, and possibly vomiting and amnesia. When a headache accompanies the hangover, it possesses symptoms similar to a migraine. The headache is global, more frequently located anteriorly, and associated with heavy, pulse-synchronous throbbing. It usually starts a few (Ͼ3) hours after the cessation of drinking, when the blood alcohol level is declining and other hangover symptoms have already developed (Sjaastad and Bakketeig, 2004) . Duration is seldom more than 12 hours. Despite its all-too-frequent occurrence, the causal mechanism(s) remain unclear. Various compounds have been implicated, notably ethanol (and its primary breakdown products, acetaldehyde and acetic acid), methanol (through its metabolic by-products, formaldehyde and formic acid), and various congeners. None of these has been adequately established as individually or collectively being the principal causal agent(s). Despite the absence of clear causal relationships, ethanol is typically viewed as the principal perpetrator. This view is supported by the physiologic effect of ethanol on the pituitary gland. Ethanol limits production of the hormone vasopressin. The result is a reduction in water reabsorption by the kidneys (increased urination), resulting in partial tissue dehydration. Contraction of the membrane covering the brain (the dura) could pull on fi bers attaching the dura to the skull, causing pain sensors to discharge. Alternately, the diuretic effect of ethanol could result in electrolytic imbalance. The resultant disruption of normal nerve and muscle function could theoretically induce symptoms such as headache, nausea and fatigue. Ethanol can also induce the breakdown of glycogen in the liver. The resulting infl ux of glucose is eliminated in the urine, producing hypoglycemia and a feeling of weakness. Finally, the breakdown of ethanol via the hepatic microsomal pathway increases the release of free radicals in the blood, causing cellular damage and a diverse range of symptoms. It is said that: Wine hath drowned more men than the sea. Because glutathione is very important in the inactivation of free radicals, taking an amino acid supplement, N-acetyl-cysteine (NAC), has been suggested as a partial remedy. NAC is rich in cysteine, an amino acid that forms the core of glutathione. In addition, glutathione facilitates the conversion of acetaldehyde to acetic acid and its subsequent metabolism, as well as binding irreversibly with acetaldehyde. The accumulation of acetaldehyde has also been proposed as a major activator of hangover initiation. For example, acetaldehyde can disrupt membrane function (partially by interfering with the action of cytochrome P-450 oxidase), and consequently cerebral neurotransmitter action. Commercial products such as Hangover Helper™ and Rebound™ have been developed to counter the effects of acetaldehyde. In addition, congeners (such as fusel alcohols and methanol) may exacerbate the effects of ethanol and acetaldehyde. Although the methanol content of wine is particularly low, its metabolism by ADH to formaldehyde, and subsequently formic acid, could be a signifi cant factor with distilled beverages. The product Chaser™ has been developed as a means of limiting the uptake of such congeners. Its formulation of activated calcium carbonate and vegetable carbon is thought to bind congeners in the stomach, preventing their uptake in the blood. Hangovers are also associated with disregulation of cytokine pathways (Kim et al., 2003) , as well as increased levels of C-reactive protein in the plasma (Wiese et al., 2004) . Some purported remedies, such as artichoke extract, have not stood up to rigorous clinical trial (Pittler et al., 2003) , but others, such as an extract of Opuntia fi scusindica (Prickly Pear), apparently reduces the severity of some hangover symptoms (Wiese et al., 2004) . It is thought to work as an infl ammatory mediator. Pyritinol (a vitamin B 6 derivative) has also been reported to reduce some hangover symptoms (Khan et al., 1973) . Regrettably, there is no known universally effective treatment for a hangover. Although time is the only sure cure, avoidance is preferable. Taking wine with meals is probably the best-known and reliable preventive, combined with limited consumption. Food delays the movement of alcohol into the intestinal tract, where some 80% of the alcohol is absorbed. Because the uptake is slowed, absorption more evenly matches the body's ability to metabolize alcohol. It also delays the uptake of phenolic compounds and diminishes their maximum concentration in the blood. Wine tasting is not normally considered hazardous to one's health. However, recent studies have found that dental erosion can be a risk (Mok et al., 2001; Mandel, 2005; Chikte et al., 2006) . Damage results from the frequent and extended exposure to wine acids. Removal of calcium softens the enamel, which becomes susceptible to erosion by masticatory forces and tooth brushing. Demineralization commences at about a pH of 5.7. This is typically not a problem for the consumer who takes wine with meals. Food and saliva secretion limit, if not prevent, demineralization of tooth enamel. After many years, professional wine tasters may experience tooth disfi guration, affecting both tooth shape and size. Cupping, a depression in the enamel, exposing dentine at the tip of molar cusps, is a frequent clinical sign. Erosion can also contribute to severe root abrasion at the gum line. Protection is partially achieved by rinsing the mouth with an alkaline mouthwash after tasting, application of a fl uoride gel (such as APF), and refraining from tooth brushing for at least one hour after tasting. The delay permits minerals in the saliva to rebind with the enamel. Fetal Alcohol Syndrome (FAS) refers to a set of phenomena including suppressed growth, mild mental retardation, and subtle facial abnormalities (Wattendorf and Muenke, 2005) . It was fi rst described in 1973 and appeared most markedly in the children of alcoholic mothers. They also tended to be heavy smokers, use illicit drugs, consume large amounts of coffee, have poor nutrition, or show a combination of these (see Scholten, 1982; Whitten, 1996) . It is suspected that alcohol is the principal cause, although the concentration and timing associated with FAS are still uncertain. Acetaldehyde accumulation may also be involved. In addition, even more subtle effects have now been detected, giving rise to the acronym FASD (fetal alcohol spectrum disorders). Because the consequences may be lifelong, it is now generally recommended that pregnant women, or women wishing to become pregnant, refrain from alcohol consumption during this period. Whether total abstinence is fully warranted is unknown, but erring on the side of caution is certainly judicious. The most important contraindication relates to those with a past history of alcohol abuse. For the majority of the adult population (except pregnant women), moderate wine consumption appears to have considerable health benefi ts. Nevertheless, there are several situations in which wine consumption, even in moderate amounts, can complicate or diminish the effectiveness of disease treatment. 1. The acidic nature of wine can aggravate the infl ammation and slow the natural healing of ulcers in the mouth, throat, stomach, and intestinal tract. Other constituents in wine may also be detrimental in this regard. Thus, all beverages containing alcohol are usually contraindicated in cases of gastritis, gastric cancer, and bleeding in the upper digestive tract. Nevertheless, the prophylactic action of red wine against Helicobacterium pylori and the suppression of histamine production by the gastric mucosa (Masquelier, 1986 ) may require a reconsideration of the old prohibition in mild cases. In the presence of pancreatitis, alcohol is absolutely contraindicated. 2. Wine, along with other alcoholic beverages, may provoke gastroesophageal (acid) refl ux in individual prone to this problem. 3. In liver disease, the consumption of wine is normally contraindicated. The presence of alcohol puts additional stress on an already weakened vital organ. Chronic alcohol abuse can lead to cirrhosis of the liver. 4. In acute kidney infection, wine should be avoided. The consumption of alcohol increases the burden on an organ essential to eliminating toxic metabolic wastes. 5. In prostatitis or genitourinary infections, the consumption of alcohol can complicate matters. The diuretic action of wine may increase the frequency of urination or, conversely, it may induce highly painful urinary retention. 6. In epilepsy, the consumption of even moderate amounts of wine may increase the frequency of seizures. 7. In patients about to undergo surgery, the effect of alcohol on reducing platelet aggregation is undesirable. Thus, it is recommended that patients terminate any alcohol (as well as aspirin) consumption before surgery. This avoids increasing the incidence of intraand postoperative bleeding (Wolfort et al., 1996) . The consumption of alcohol is also ill advised when eating certain mushrooms. The most well-known example is the antabuse reaction associated with simultaneous consumption with Coprinus atramentarius (Inky Cap). Another mushroom generating the same response is Boletus luridus (Budmiger and Kocher, 1982) . The antabuse reaction derives its name from the trade name of disulfi ram, a medication used in the treatment of alcoholism. It functions as an inhibitor of acetaldehyde dehydrogenase. Even when small amounts of alcohol are consumed along with disulfi ram, it induces a very unnerving reaction. This may include fl ushing, sweating, weakness, vertigo, blurred vision, diffi culty breathing, nausea, chest pain, palpitation, and tachycardia. In severe cases, the reaction can provoke acute congestive heart failure, convulsion, and death. Simultaneous consumption of alcoholic beverages while using certain drugs (e.g., cephalosporins, griseofulvin, chloramphenicol, sulfonylurea, metronidazole) can produce similar symptoms in sensitive individuals. In addition to the antabuse reaction just noted, consumption of alcohol can generate various unpleasant to dangerous reactions. Regrettably, most of the literature relating to alcohol-drug interactions comes from studies on alcoholics or binge drinkers. This limits their potential applicability under conditions of moderate consumption with meals. Nevertheless, even small amounts of alcohol may cause loss of muscle control in people taking tricyclic antidepressants. In addition, red wines can reduce the effectiveness of MAO (monoamine oxidase) inhibitors used in controlling hypertension. The long-term use of acetaminophen can enhance alcohol-induced kidney damage. Other contraindications involve the intensifi cation of the effects of barbiturates and narcotics. In combination with certain antidiabetic agents, such as tolbutamide and chlorpropamide, alcohol can cause dizziness, hot fl ushes, and nausea. Mild reactions may occur with a wide range of other medications, such as sulfanilamide, isoniazid, and aminopyrine. Details can be found in Adams (1995) , Fraser (1997) , and Weathermon and Crabb (1999) . Therapeutic potential of resveratrol: the in vivo evidence Antimicrobial activity of fl avonoids Wine, alcohol and atherosclerosis: clinical evidences and mechanisms. Brazil Resveratrol as an antiinfl ammatory and anti-aging agent: mechanisms and clinical implications Nutraceuticals as anti-angiogenic agents: hopes and reality The health benefi ts of wine Adverse reactions to wine Plant defense and human nutrition: phenylpropanoids on the menu Atherosclerosis: The new view Alcohol: Its metabolism and interaction with nutrients A History of Wine as Therapy Emerging role of polyphenolic compounds in the treatment of neurodegenerative diseases: a review of their intracellular targets Structureantioxidant activity relationships of fl avonoids and phenolic acids. Free Radic Wine: A Scientifi c Exploration Better wine for better health: Faction or fi ction Vascular protection by dietary polyphenols Allergic and asthmatic reactions to alcoholic drinks Interactions between alcohol and other drugs Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies Platelet sulphotransferase activity, plasma sulfate levels, and sulphation capacity in patients with migraine and tension headache Effects of loratadine in red wine-induced symptoms and signs of rhinitis Alcohol consumption and acute myocardial infarction: a benefi t of alcohol consumed with meals? Wine fl avonoids protect against LDL oxidation and atherosclerosis The relative antioxidant potencies of some polyphenols in grapes and wines Type of alcoholic beverage and cancer of the oral cavity, pharynx and oesophagus in an Italian area with high wine consumption Alcohol and the NIDDM patient Effect of red wine, minor constituents, and alcohol on the gastric emptying and the metabolic effects of a solid digestible meal Modulatory effect of resveratrol, a natural phytoalexin, on endothelial adhesion molecules and intracellular signal transduction The role of moderate ethanol consumption in health and human nutrition Yeast eicosanoids, IV. Evidence for prostaglandin production during ascosporogenesis by Dipodascopsis tothii Relation of smoking, alcohol and coffee consumption to active Helicobacterium pylori infection: Cross sectional study The role of vanadium in the management of diabetes Boletus luridus and alcohol. Case report (in German) Prospective study of moderate alcohol consumption and risk of peripheral arterial disease in US male physicians Patterns of tooth surface loss among winemakers Alcohol intake and risk of incident gout in men: a prospective study Pathogenesis of gout Resveratrol is a selective human cytochrome P450 1A1 inhibitor Smoking, alcohol consumption, and susceptibility to the common cold Endothelin-1 synthesis reduced by red wine A review of the clinical presentation and laboratory fi ndings of two uncommon hereditary disorders of sulfur amino acid metabolism, β-mercaptolactate cysteine disulfi deuria and sulfi te oxidase defi ciency Beverage use and risk for kidney stones in women Red wine asthma: A controlled study Nephelometric study of salivary protein-tannin aggregates Is dopamine behind the health benefi ts of red wine? Resveratrol-induced apoptosis is associated with Fas redistribution in the rafts and the formation of a death-inducing signaling complex in colon cancer cells Polymeric proanthocyanidins are catabolized by human colonic microfl ora into low-molecular-weight phenolic acids Dietary fi ber in wine Alcohol consumption in the severely obese: relationship with the metabolic syndrome Inhibitory activity of diluted wine on bacterial growth: the secret of water purifi cation in antiquity Mortality in relation to alcohol consumption: a prospective study among male British doctors Wine and cancer /1987) When the Empire struck lead Genotyping of the aldehyde dehydrogenase 2(ALDH2) gene using the polymerase chain reaction: evidence for single point mutation in the ALDH2 gene for ALDH2-defi ciency Migration of lead into alcoholic beverages during storage in lead crystal decanters Strand scission in DNA by quercetin and Cu(II): Identifi -cation of free radical intermediates and biological consequences of scission Reduction in the direct-acting mutagenic activity of red wine by treatment with polyvinylpolypyrrolidone Effects of ethanol and some alcoholic beverages on gastric emptying in humans Inhibition of human LDL oxidation by resveratrol Pharmacokinetic interactions between alcohol and other drugs Smoking, alcohol intake, estrogen use, and age-related macular degeneration in Latinos: the Los Angeles Latino Eye Study The in vitro effect of red wine on Helicobacterium pylori White wine with red wine-like properties: increased extraction of grape skin polyphenols improves the antioxidant capacity of the derived white wine Effect of alcohol intake on bone mineral density in elderly women: The EPIDOS Study. Epidemiologie de l'Osteoporose Type of alcoholic beverage and risk of myocardial infarction Shortterm effect of red wine (consumed during meals) on insulin requirement of glucose tolerance in diabetic patients Red head Type of alcohol consumed and mortality from all causes, coronary heart disease, and cancer Alcoholism and neuro-immune-endocrine interactions: physiochemical aspects Staying sober Oxidants, antioxidants, alcohol and stroke Genetic variation in alcohol dehydrogenase and the benefi cial effect of moderate alcohol consumption on myocardial infarction Potential mechanism of cancer chemoprevention by anthocyanins Parotid salivation in response to tasting wine To drink or not to drink: how are alcohol, caffeine and past smoking related to bone mineral density in elderly women? Flavonoids protect neuronal cells from oxidative stress by three distinct mechanisms. Free Radic Resveratrol blocks eicosanoid production and chemically-induced cellular transformation: Implications for cancer chemoprevention Wine and headache Reduced platelet phenolsulphotransferase activity towards dopamine and 5-hydroxytryptamine in migraine Platelet aggregation in migraine patients during the headache-free interval Antimutigenicity of fl avones and fl avonols to heterocyclic amines by specifi c and strong inhibition of the cytochrome P450 1A family The stomach as a bioreactor: dietary lipid peroxidation in the gastric fl uid and the effects of plantderived antioxidants. Free Radic Wine and the elderly person The red wine headache: A pilot study of a specifi c syndrome The red wine headache and prostaglandin synthetase inhibitors: A blind controlled study Alcohol, blood pressure and hypertension Dietary fl avonoids, antioxidant vitamins and the incidence of stroke: the Zutphen Study Alcohol-induced hangover. A double-blind comparison of pyritinol and placebo in preventing hangover symptoms Effects of alcohol hangover on cytokine production in healthy subjects Alcohol consumption before myocardial infarction: Results from the Kaiser-Permanente epidemiologic study of myocardial infarction Wine, liquor, beer, and mortality Drinker prototypes in American Society Alcohol consumption is associated with reduced prevalence of goitre and solitary thyroid nodules The relationship of alcohol consumption to arteriosclerotic heart disease A central role of eNOS in the protective effect of wine against metabolic syndrome Risk of dementia and alcohol and wine consumption: a review of recent results Association between consumption of beer, wine, and liquor and plasma concentration of high-sensitivity C-reactive protein in women aged 39 to 89 years Atherosclerosis: A new view Why can't Chinese Han drink alcohol? Hepatis B virus infection and the evolution of acetaldehyde dehydrogenase defi ciency Alcohol intake and risk of dementia A History of Wine as Therapy Dental erosion due to wine consumption Resveratrol promotes clearance of Alzheimer's disease amyloid-beta peptides Allergic symptoms from fi ning agents used in winemaking Human parotid secretion in response to ethyl alcohol Azione portettrice del vino sull'ulcera gastrica Effets physiologiques du vin. Sa part dans l'alcoolisme The red wine reaction syndrome Wine antioxidants and their impact on antioxidant activity in vivo Red wine and antioxidant activity in serum Alcohol-induced generation of lipid peroxidation products in humans Effect of plant fl avonoids on immune and infl ammatory cell function Antioxidant activity of resveratrol in red wine Antihistamine blockade of alcohol-induced fl ushing in orientals Dental erosion: In vitro model of a wine assessor's erosion Role of fl avonoids and iron chelation in antioxidant action Wine is bactericidal to foodborne pathogens Alcohol consumption and risk for coronary heart disease in men with healthy lifestyles Alcohol in American History Red wine consumption improves insulin resistance but not endothelial function in type 2 diabetic patients The addicted brain Wine and migraine: compatibility or incompatibility? Hemoglobin-acetaldehyde adducts in human alcohol abusers Alcoholic macrocytosis -is there a role for acetaldehyde and adducts? Seeking the connections: alcoholism and our genes Moderate wine consumption is associated with decreased odds of developing age-related macular degeneration in NHANES-1 Anitamyloidogenic activity of tannic acid and its activity to destabilize Alzheimer's beta-amyloid fi brils in vitro Prostaglandins in alcohol intolerance and hangover The stomach as a site for anthocyanins absorption from food Fast access of some grape pigments to the brain Identifi cation of grape and wine allergens as an endochitinase 4, a lipid-transfer protein, and a thaumatin 5-Hydroxytryptamine release from platelets by different red wines: Implications for migraine Prostacyclin, tyramine and red wine Effectiveness of artichoke extract in preventing alcohol-induced hangovers: a randomized controlled trial Cross-cultural aspects of drinking, alcohol abuse and alcoholism Red wine antioxidants. Evaluation of their hydrophobicity and binding extent to salivary proteins Wine alcohol, platelets and the French paradox for coronary heart disease Effects of alcohol on platelet functions Alcohol and mortality from all causes Structureantioxidant activity relationships of fl avonoids and phenolic acids The effects of carbon dioxide in champagne on psychometric performance and blood-alcohol concentration Review of moderate alcohol consumption and reduced risk of coronary heart disease: Is the effect due to beer, wine, or spirits? Inhibitory effects of plant phenols on the activity of selected enzymes Potential food allergens in wine: doubleblind, placebo-controlled trial and basophil activation analysis Low prevalence of the metabolic syndrome in wine drinkers -is it the alcohol beverage or the lifestyle? Absorption and metabolism of polyphenols in the gut and impact on health Alcoholism: The Health and Social Consequences of Alcohol Use Blood alcohol concentrations resulting from wine drinking timed according to the dietary habits of Italians. Quart Sulfi te oxidase defi ciency Plasma levels of caffeic acid and antioxidant status after red wine intake Oxidation of wines. l. Young white wines periodically exposed to air Hangover headache: various manifestations and proposal for criteria. Vågå study of headache epidemiology Potential health impacts of excessive fl avonoid intake. Free Rad Heavy drinking and problems among wine drinkers Ultrasensitive assay for three polyphenols (catechin, quercetin and resveratrol) and their conjugates in biological fl uids utilizing gas chromatography with mass selective detection Alcohol consumption, mild cognitive imparment, and progression to dementia Double-blind placebo-controlled trial of lithium in episodic cluster headache Sleep and low doses of alcohol Resveratrol, a red wine antioxidant, possesses an insulin-like effect in streptozotocin-induced diabetic rats Resveratrol inhibits the expression of cyclooxygenase-2 in human mammary and oral epithelial cells Effect of some phenolic compounds and beverages on pepsin activity during simulated gastric digestion The contribution of polymorphism in the alcohol dehydrogenase bets subunit to alcohol sensitivity in a Japanese population Association of the ADH2 genotypes with skin responses after ethanol exposure in Japanese male university students Intake of wine, beer, and spirits and the risk of clinical common cold Anthocyanins are efficiently absorbed from the small intestine in rats Contribution to wine in vanadium dietary intake: Geographical origin has a signifi cant impact on wine vanadium levels ADH3 genotype, alcohol intake, and breast cancer risk Maleic acid and succinic acid in fermented alcoholic beverages are the stimulants of gastric acid secretion ADH2 gene polymorphism are determinants of alcohol pharmacokinetics Alcohol consumption and mortality among middle-aged and elderly US adults Resveratrol, MAP kinases and neuronal cells: might wine be a neuroprotectant? Intake of beer, wine, and spirits and risk of stroke: The Copenhagen city heart study Amount and type of alcohol and risk of dementia: the Copenhagen City Heart Study Aspirin attenuation of alcohol-induced fl ushing and intoxication in oriental and occidental subjects Alcohol in the western world Role of sulfi te additives in wine induced asthma: single dose and cumulative dose studies Alcohol consumption stimulates early steps in reverse cholesterol transport Nitric oxide radical scavenging by wines Alcoholic calories, red wine consumption and breast cancer among premenopausal women Food-derived mutagens and carcinogens Genetic association of alcohol dehydrogenase with alcohol use disorders and endophenotypes in white college students A blend of polyphenolic compounds explains the stimulatory effect of red wine on human endothelial NO synthase Alterosclerotic cardiovascular disease and antioxidants Older plasma lipoproteins are more susceptible to oxidation: A linking mechanism for the lipid and oxidation theories of atherosclerotic cardiovascular disease Histamine in wine -bronchoconstriction after a doubleblind placebo-controlled red wine provocation test Supplementation with grape seed polyphenols results in increased urinary excretion of 3-hydroxyphenylpropionic acid, an important metabolite of proanthocyanidins in humans Fetal alcohol spectrum disorders Alcohol and medication interactions Investigation of the allergenic potential of wines fi ned with various proteinogenic fi ning agents by ELISA Nutritional approach to cancer prevention with emphasis on vitamins, antioxidants, and carotenoids Wine as a digestive aid: Comparative antimicrobial effects of bismuth salicylate and red and white wine Fetal alcohol risk: A current perspective The alcohol hangover Effect of Opuntia fi scus indica on symptoms of the alcohol hangover Flavonoids: antioxidants or signalling molecules? Free Radic Bioavailability and bioeffi cacy of polyphenols in humans. II. Review of 93 intervention studies Alcohol and preoperative management Flavonoid permeability across an in situ model of the blood-brain barrier. Free Radic Lead nephropathy and gout Alcohol consumption and risk of breast cancer: The Framingham Study revisited Waterhouse, A. L., and Rantz, J. M. (eds.) (1996)